Zura Bio Q2 EPS $(1.31) Misses $(0.25) Estimate
Portfolio Pulse from Benzinga Newsdesk
Zura Bio (NASDAQ:ZURA) reported Q2 losses of $(1.31) per share, missing the analyst consensus estimate of $(0.25) by 424 percent. However, this is an 86.27 percent increase over losses of $(9.54) per share from the same period last year.
August 14, 2023 | 11:27 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Zura Bio's Q2 earnings missed estimates, but showed improvement over last year's losses.
Zura Bio's Q2 earnings missed analyst estimates significantly, which could negatively impact investor sentiment and the stock price in the short term. However, the year-over-year improvement in losses might provide some positive sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100